Edition:
United States

Trovagene Inc (TROV.O)

TROV.O on Consolidated Issue listed on NASDAQ Capital Market

0.65USD
26 May 2017
Change (% chg)

$-0.04 (-5.64%)
Prev Close
$0.69
Open
$0.74
Day's High
$0.74
Day's Low
$0.65
Volume
324,154
Avg. Vol
322,509
52-wk High
$5.98
52-wk Low
$0.65

Latest Key Developments (Source: Significant Developments)

Trovagene announces Q1 loss per share $0.32
Wednesday, 10 May 2017 04:05pm EDT 

May 10 (Reuters) - Trovagene Inc :Trovagene announces first quarter 2017 company highlights and financial results.Q1 loss per share $0.32.  Full Article

Trovagene reports Q4 loss per share $0.34
Wednesday, 15 Mar 2017 04:04pm EDT 

Trovagene Inc : Trovagene reports fourth quarter and year end 2016 financial results . Q4 loss per share $0.34 . Q4 earnings per share view $-0.32 -- Thomson Reuters I/B/E/S . Trovagene Inc - estimates restructuring program will reduce annual pre-tax expenses by approximately $8.0 million per year .Trovagene - Restructuring program includes reduction of about 30 personnel and expenses primarily linked to research, clinical studies and operations.  Full Article

Trovagene, Nerviano announce license agreement for therapeutic candidate PCM-075
Wednesday, 15 Mar 2017 04:02pm EDT 

Trovagene Inc : Trovagene and Nerviano announce license agreement for therapeutic candidate PCM-075 . Trovagene Inc says Trovagene will assume sole responsibility for global development and commercialization of pcm-075 . Trovagene Inc- under terms of license agreement, trovagene will assume sole responsibility for global development and commercialization of pcm-075 . Trovagene inc says Nerviano will receive an upfront payment of $2.0 million, as well as development and regulatory-based milestone payments . Trovagene Inc - co, Nerviano medical sciences signed agreement grants co exclusive global development and commercialization rights to nms-1286937 . Trovagene Inc says Nerviano will also receive royalty payments on future net sales of PCM-075 .Trovagene Inc - Trovagene plans to develop PCM-075 initially in aml.  Full Article

Trovagene to accelerate global distribution of liquid biopsy technology
Tuesday, 13 Dec 2016 04:05pm EST 

Trovagene Inc : Estimates program will reduce annual pre-tax expenses by about $4.0m per year mainly through reduction of about 20 personnel and expenses .Announces a reorganization to accelerate global distribution of liquid biopsy technology.  Full Article

Trovagene and Boreal Genomics announce strategic partnership
Wednesday, 30 Nov 2016 08:00am EST 

Trovagene Inc : Press release - Trovagene and Boreal Genomics announce strategic partnership .Trovagene - co, boreal have contributed technology to enhance ctdna detection capabilities to develop series of multigene panels planned for launch in 2017.  Full Article

Trovagene reports Q2 loss per share $0.34
Thursday, 4 Aug 2016 04:15pm EDT 

Trovagene Inc : Q2 loss per share $0.34 . Trovagene reports second quarter 2016 financial results and accomplishments .Q2 earnings per share view $-0.31 -- Thomson Reuters I/B/E/S.  Full Article

Trovagene entered into Fifth amendment to loan and security agreement with Oxford Finance, Silicon Valley Bank
Tuesday, 26 Jul 2016 04:32pm EDT 

Trovagene Inc : On July 20, 2016, Co entered into Fifth amendment to loan and security agreement with Oxford Finance LLC, Silicon Valley Bank .Maturity date of loan was amended to february 1, 2020 - sec filing.  Full Article

Trovagene files for mixed shelf of up to $250 million
Friday, 27 May 2016 05:23pm EDT 

Trovagene Inc :Files for mixed shelf of up to $250 million - SEC filing.  Full Article

Trovagene Q1 loss per share $0.36
Tuesday, 10 May 2016 04:49pm EDT 

Trovagene Inc : Trovagene announces first quarter 2016 financial results . Q1 loss per share $0.36 .Q1 earnings per share view $-0.29 -- Thomson Reuters I/B/E/S.  Full Article

Trovagene Inc enters into preferred provider agreement with Multiplan Inc
Tuesday, 1 Mar 2016 08:15am EST 

Trovagene Inc:Entered into an agreement with Multiplan Inc for participation in PHCS, Multiplan and Beech Street Networks.  Full Article

More From Around the Web

BRIEF-Trovagene announces Q1 loss per share $0.32

* Trovagene announces first quarter 2017 company highlights and financial results